NLRP3 and cryopyrin-associated periodic syndrome: Sensorineural deafness is a prominent characteristic of CAPS, a spectrum of conditions caused by activating mutations in NLRP3 leading to deregulated release of active IL-1β (Aganna et al., 2002), which are effectively treated with IL-1 blockade.